|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-23
|
|
pubmed:abstractText |
Allografting induces long-term molecular remissions and possibly cure in myeloma patients. The development of non-myeloablative conditionings has reduced the transplant-related mortality (TRM) associated with myeloablation and extended the eligible age for transplantation. Moreover, high response rates are reported especially when allografting is preceded by cytoreductive high-dose chemotherapy. We investigated the feasibility of unrelated donor non-myeloablative transplantation as either part of the initial treatment plan or as salvage treatment in heavily pretreated patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0902-4441
|
|
pubmed:author |
pubmed-author:BacigalupoAndreaA,
pubmed-author:BoccadoroMarioM,
pubmed-author:BosiAlbertoA,
pubmed-author:BrunoBenedettoB,
pubmed-author:BuscaAlessandroA,
pubmed-author:ConsoleGiuseppeG,
pubmed-author:CorradiniPaoloP,
pubmed-author:DominiettoAlidaA,
pubmed-author:FaldaMicheleM,
pubmed-author:FaninRenatoR,
pubmed-author:GiacconeLuisaL,
pubmed-author:Gruppo Italiano Trapianto Midollo Osseo,
pubmed-author:GuidiStefanoS,
pubmed-author:MarottaGiuseppeG,
pubmed-author:MeugnierMM,
pubmed-author:MiloneGiuseppeG,
pubmed-author:MontefuscoVittorioV,
pubmed-author:PollichieniSimonaS,
pubmed-author:RottaMarcelloM,
pubmed-author:SciméRosannaR,
pubmed-author:SorasioRobertoR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
330-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17331132-Adult,
pubmed-meshheading:17331132-Disease Progression,
pubmed-meshheading:17331132-Disease-Free Survival,
pubmed-meshheading:17331132-Female,
pubmed-meshheading:17331132-Follow-Up Studies,
pubmed-meshheading:17331132-Graft vs Host Disease,
pubmed-meshheading:17331132-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17331132-Humans,
pubmed-meshheading:17331132-Male,
pubmed-meshheading:17331132-Middle Aged,
pubmed-meshheading:17331132-Multiple Myeloma,
pubmed-meshheading:17331132-Neoplasm Staging,
pubmed-meshheading:17331132-Risk Factors,
pubmed-meshheading:17331132-Salvage Therapy,
pubmed-meshheading:17331132-Survival Rate,
pubmed-meshheading:17331132-Transplantation, Homologous,
pubmed-meshheading:17331132-Transplantation Conditioning,
pubmed-meshheading:17331132-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.
|
|
pubmed:affiliation |
Division of Hematology at the San Giovanni Battista Hospital, University of Torino, Torino, Italy. benedetto.bruno@unito.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
